Time-dependent recovery of in vivo binding sites after drug dosing: A method for radiotracer evaluation

This publication has 10 references indexed in Scilit:

• Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains
  European Journal of Pharmacology, 1996
• Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
  Nuclear Medicine and Biology, 1996
• [3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity
  Neuroscience, 1995
• Time‐course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex
  Synapse, 1995
• Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3?-(4-Iodophenyl)Tropane-2-Carboxylic acid Methyl Ester: RTI-55 or ?CIT
  Synapse, 1995
• Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter
  Nuclear Medicine and Biology, 1994
• Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies
  Applied Radiation and Isotopes, 1993
• Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors
  Neuropharmacology, 1992
• Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site
  European Journal of Pharmacology, 1992
• Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[¹¹C]Deprenyl
  Journal of Neurochemistry, 1987